Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Atoltivimab

SKU: orb1980595

Description

Atoltivimab (REGN3470), also known as maftivimab/odesivimab (Inmazeb), represents the first monoclonal antibody approved by the Food and Drug Administration (FDA) to combat Zaire ebolavirus (EBOV) infection [1].

Images & Validation

Key Properties

ClonalityMonoclonal
TargetAtoltivimab
Purity98.00%
ConjugationUnconjugated

Storage & Handling

StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • EBOV Reference Antibody (Atoltivimab) [orb1818121]

    FC,  Kinetics

    Virus

    Monoclonal

    Unconjugated

    100 μg
  • Atoltivimab (Zaire Ebola virus) - Research Grade Biosimilar [orb1237859]

    Recombinant

    Unconjugated

    0.1 mg
  • Maftivimab [orb2703576]

    Unconjugated

    100 mg
  • Atoltivimab [orb2703592]

    Monoclonal

    Unconjugated

    100 mg
  • Maftivimab [orb1980370]

    Unconjugated

    5 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

Free Secondary Antibody (20 ul)0/0

Please add an antibody product to your cart first.